hrp0082p3-d1-627 | Adrenals & HP Axis | ESPE2014
Cinaz Peyami
, Cihan Emeksiz Hamdi
, Celik Nurullah
, Doger Esra
, Yuce Ozge
, Camurdan Orhun
, Bideci Aysun
Background: P450 oxidoreductase (POR) deficiency is the newest form of congenital adrenal hyperplasia first described in 2004. POR is a protein that transfers electrons from NADPH to all 50 microsomal forms of cytochrome P450. Mutations that cause POR deficiency result in partial deficiency of the enzymes 21-hydroxylase and 17α-hydroxylase. Remarkable clinical features of the POR deficiency are genital ambiguity in both sexes, glucocorticoid deficiency and Antley-Bixler s...